Analgesics
Antiandrogens
Antihistamines
Azvudine
Bromhexine
Budesonide
Colchicine
Conv. Plasma
Curcumin
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Ivermectin
Lifestyle
Melatonin
Metformin
Minerals
Molnupiravir
Monoclonals
Naso/orophar..
Nigella Sativa
Nitazoxanide
PPIs
Paxlovid
Quercetin
Remdesivir
Thermotherapy
Vitamins
More

Other
Feedback
Home
 
next
study
previous
study
c19early.org COVID-19 treatment researchMetforminMetformin (more..)
Melatonin Meta
Metformin Meta
Antihistamines Meta
Azvudine Meta Molnupiravir Meta
Bromhexine Meta
Budesonide Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta PPIs Meta
Famotidine Meta Paxlovid Meta
Favipiravir Meta Quercetin Meta
Fluvoxamine Meta Remdesivir Meta
Hydroxychlor.. Meta Thermotherapy Meta
Ivermectin Meta

All Studies   Meta Analysis       

Prevalent Metformin Use in Adults With Diabetes and the Incidence of Long COVID: An EHR-Based Cohort Study From the RECOVER Program

Johnson et al., Diabetes Care, doi:10.2337/DCa24-0032
Sep 2024  
  Post
  Facebook
Share
  Source   PDF   All Studies   Meta AnalysisMeta
Death or long COVID, com.. 11% Improvement Relative Risk Death or long COVID, N3.. 21% Death or long COVID.. (b) 15% Death or long COVID, PC.. 13% Death or long COVID.. (b) -4% Metformin for COVID-19  Johnson et al.  Prophylaxis Is prophylaxis with metformin beneficial for COVID-19? Retrospective 48,988 patients in the USA Lower progression with metformin (not stat. sig., p=0.11) c19early.org Johnson et al., Diabetes Care, September 2024 Favorsmetformin Favorscontrol 0 0.5 1 1.5 2+
Metformin for COVID-19
3rd treatment shown to reduce risk in July 2020, now with p < 0.00000000001 from 99 studies.
No treatment is 100% effective. Protocols combine treatments.
5,100+ studies for 112 treatments. c19early.org
N3C/PCORnet retrospective adults with type 2 diabetes in the USA showing lower incidence of mortality or long COVID with metformin use.
death or long COVID, 11.3% lower, HR 0.89, p = 0.11, treatment 42,275, control 6,713, combined.
death or long COVID, 21.0% lower, HR 0.79, p < 0.001, treatment 42,275, control 6,713, N3C, EHR code.
death or long COVID, 15.0% lower, HR 0.85, p < 0.001, treatment 42,275, control 6,713, N3C, phenotype.
death or long COVID, 13.0% lower, HR 0.87, p = 0.32, treatment 30,748, control 5,933, PCORnet, EHR code.
death or long COVID, 4.0% higher, HR 1.04, p = 0.26, treatment 30,748, control 5,933, PCORnet, phenotype.
Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates
Johnson et al., 17 Sep 2024, retrospective, USA, peer-reviewed, 19 authors.
This PaperMetforminAll
{ 'indexed': {'date-parts': [[2024, 9, 17]], 'date-time': '2024-09-17T18:40:21Z', 'timestamp': 1726598421108}, 'reference-count': 0, 'publisher': 'American Diabetes Association', 'license': [ { 'start': { 'date-parts': [[2024, 9, 17]], 'date-time': '2024-09-17T00:00:00Z', 'timestamp': 1726531200000}, 'content-version': 'vor', 'delay-in-days': 0, 'URL': 'https://www.diabetesjournals.org/journals/pages/license'}], 'funder': [ { 'DOI': '10.13039/100006108', 'name': 'National Center for Advancing Translational Sciences', 'doi-asserted-by': 'publisher', 'award': ['UM1TR004406', 'UM1TR004528'], 'id': [{'id': '10.13039/100006108', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}, { 'DOI': '10.13039/100000062', 'name': 'National Institute of Diabetes and Digestive and Kidney Diseases', 'doi-asserted-by': 'publisher', 'award': ['DK124654'], 'id': [{'id': '10.13039/100000062', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}, {'name': 'NC Diabetes Research Center', 'award': ['P30DK124723']}, { 'DOI': '10.13039/100000050', 'name': 'National Heart, Lung, and Blood Institute', 'doi-asserted-by': 'publisher', 'award': ['OT2HL16184701'], 'id': [{'id': '10.13039/100000050', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}, { 'DOI': '10.13039/100000049', 'name': 'National Institute on Aging', 'doi-asserted-by': 'publisher', 'award': ['AG056479'], 'id': [{'id': '10.13039/100000049', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}], 'content-domain': {'domain': ['diabetesjournals.org'], 'crossmark-restriction': True}, 'abstract': '<jats:sec>\n' ' <jats:title>OBJECTIVE</jats:title>\n' ' <jats:p>Studies show metformin use before and during SARS-CoV-2 infection ' 'reduces severe COVID-19 and postacute sequelae of SARS-CoV-2 (PASC) in adults. Our objective ' 'was to describe the incidence of PASC and possible associations with prevalent metformin use ' 'in adults with type 2 diabetes mellitus (T2DM).</jats:p>\n' ' </jats:sec>\n' ' <jats:sec>\n' ' <jats:title>RESEARCH DESIGN AND METHODS</jats:title>\n' ' <jats:p>This is a retrospective cohort analysis using the National COVID ' 'Cohort Collaborative (N3C) and Patient-Centered Clinical Research Network (PCORnet) ' 'electronic health record (EHR) databases with an active comparator design that examined ' 'metformin-exposed individuals versus nonmetformin-exposed individuals who were taking other ' 'diabetes medications. T2DM was defined by HbA1C ≥6.5 or T2DM EHR diagnosis code. The outcome ' 'was death or PASC within 6 months, defined by EHR code or computable phenotype.</jats:p>\n' ' </jats:sec>\n' ' <jats:sec>\n' ' <jats:title>RESULTS</jats:title>\n' ' <jats:p>In the N3C, the hazard ratio (HR) for death or PASC with a U09.9 ' 'diagnosis code (PASC-U09.0) was 0.79 (95% CI 0.71–0.88; P &amp;lt; 0.001), and for death or ' 'N3C computable phenotype PASC (PASC-N3C) was 0.85 (95% CI 0.78–0.92; P &amp;lt; 0.001). In ' 'PCORnet, the HR for death or PASC-U09.9 was 0.87 (95% CI 0.66–1.14; P = 0.08), and for death ' 'or PCORnet computable phenotype PASC (PASC-PCORnet) was 1.04 (95% CI 0.97–1.11; P = 0.58). ' 'Incident PASC by diagnosis code was 1.6% metformin vs. 2.0% comparator in the N3C, and 2.1% ' 'metformin vs. 2.5% comparator in PCORnet. By computable phenotype, incidence was 4.8% ' 'metformin and 5.2% comparator in the N3C and 24.7% metformin vs. 26.1% comparator in ' 'PCORnet.</jats:p>\n' ' </jats:sec>\n' ' <jats:sec>\n' ' <jats:title>CONCLUSIONS</jats:title>\n' ' <jats:p>Prevalent metformin use is associated with a slightly lower ' 'incidence of death or PASC after SARS-CoV-2 infection. PASC incidence by computable phenotype ' 'is higher than by EHR code, especially in PCORnet. These data are consistent with other ' 'observational analyses showing prevalent metformin is associated with favorable outcomes ' 'after SARS-CoV-2 infection in adults with T2DM.</jats:p>\n' ' </jats:sec>', 'DOI': '10.2337/dca24-0032', 'type': 'journal-article', 'created': {'date-parts': [[2024, 9, 17]], 'date-time': '2024-09-17T17:58:16Z', 'timestamp': 1726595896000}, 'update-policy': 'http://dx.doi.org/10.2337/ada-journal-policies', 'source': 'Crossref', 'is-referenced-by-count': 0, 'title': 'Prevalent Metformin Use in Adults With Diabetes and the Incidence of Long COVID: An EHR-Based ' 'Cohort Study From the RECOVER Program', 'prefix': '10.2337', 'author': [ { 'ORCID': 'http://orcid.org/0000-0002-2983-6384', 'authenticated-orcid': False, 'given': 'Steven G.', 'family': 'Johnson', 'sequence': 'first', 'affiliation': [ { 'name': '1Institute for Health Informatics, University of Minnesota, ' 'Minneapolis, MN'}]}, { 'given': 'Sajjad', 'family': 'Abedian', 'sequence': 'additional', 'affiliation': [ { 'name': '2Information Technologies and Services Department, Weill Cornell ' 'Medicine, New York, NY'}]}, { 'given': 'Til', 'family': 'Stürmer', 'sequence': 'additional', 'affiliation': [ { 'name': '3Department of Epidemiology, Gillings School of Global Public ' 'Health, University of North Carolina at Chapel Hill, Chapel ' 'Hill, NC'}]}, { 'given': 'Jared D.', 'family': 'Huling', 'sequence': 'additional', 'affiliation': [ { 'name': '4Division of Biostatistics and Health Data Science, University ' 'of Minnesota School of Public Health, Minneapolis, MN'}]}, { 'given': 'Colby', 'family': 'Lewis V', 'sequence': 'additional', 'affiliation': [ { 'name': '5Department of Population Health Sciences, Weill Cornell ' 'Medicine, New York, NY'}]}, { 'ORCID': 'http://orcid.org/0000-0002-9723-3876', 'authenticated-orcid': False, 'given': 'John B.', 'family': 'Buse', 'sequence': 'additional', 'affiliation': [ { 'name': '6Division of Endocrinology, Department of Medicine, University ' 'of North Carolina School of Medicine, Chapel Hill, NC'}]}, { 'given': 'Shari B.', 'family': 'Brosnahan', 'sequence': 'additional', 'affiliation': [ { 'name': '7Department of Medicine, New York University Grossman School of ' 'Medicine, New York, NY'}]}, { 'given': 'Praveen C.', 'family': 'Mudumbi', 'sequence': 'additional', 'affiliation': [ { 'name': '8Department of Population Health, New York University Grossman ' 'School of Medicine, New York, NY'}]}, { 'given': 'Kristine M.', 'family': 'Erlandson', 'sequence': 'additional', 'affiliation': [{'name': '9University of Colorado, Anschutz Medical Campus, Aurora, CO'}]}, { 'given': 'Grace A.', 'family': 'McComsey', 'sequence': 'additional', 'affiliation': [{'name': '10Case Western Reserve University, Cleveland, OH'}]}, { 'given': 'Jonathan', 'family': 'Arnold', 'sequence': 'additional', 'affiliation': [ { 'name': '11Division of General Internal Medicine, University of ' 'Pittsburgh School of Medicine, Pittsburgh, PA'}]}, { 'given': 'Talia D.', 'family': 'Wiggen', 'sequence': 'additional', 'affiliation': [ { 'name': '1Institute for Health Informatics, University of Minnesota, ' 'Minneapolis, MN'}]}, { 'given': 'Rachel', 'family': 'Wong', 'sequence': 'additional', 'affiliation': [ { 'name': '12Department of Biomedical Informatics and the Department of ' 'Internal Medicine, Stony Brook University, Stony Brook, NY'}]}, { 'given': 'Shawn', 'family': 'Murphy', 'sequence': 'additional', 'affiliation': [{'name': '13Mass General Brigham, Boston, MA'}]}, { 'given': 'Clifford', 'family': 'Rosen', 'sequence': 'additional', 'affiliation': [{'name': '14MaineHealth Institute for Research, Scarborough, ME'}]}, { 'given': 'Rainu', 'family': 'Kaushal', 'sequence': 'additional', 'affiliation': [ { 'name': '5Department of Population Health Sciences, Weill Cornell ' 'Medicine, New York, NY'}]}, { 'given': 'Mark G.', 'family': 'Weiner', 'sequence': 'additional', 'affiliation': [ { 'name': '5Department of Population Health Sciences, Weill Cornell ' 'Medicine, New York, NY'}]}, { 'given': 'Carolyn', 'family': 'Bramante', 'sequence': 'additional', 'affiliation': [ { 'name': '15Division of General Internal Medicine, Department of Medicine, ' 'University of Minnesota Medical School, Minneapolis, MN'}]}, { 'name': 'RECOVER PCORnet EHR Cohort and the N3C Consortium', 'sequence': 'additional', 'affiliation': []}], 'member': '1167', 'published-online': {'date-parts': [[2024, 9, 17]]}, 'container-title': 'Diabetes Care', 'original-title': [], 'language': 'en', 'link': [ { 'URL': 'https://diabetesjournals.org/care/article-pdf/doi/10.2337/DCa24-0032/781872/dca240032.pdf', 'content-type': 'application/pdf', 'content-version': 'vor', 'intended-application': 'syndication'}, { 'URL': 'https://diabetesjournals.org/care/article-pdf/doi/10.2337/DCa24-0032/781872/dca240032.pdf', 'content-type': 'unspecified', 'content-version': 'vor', 'intended-application': 'similarity-checking'}], 'deposited': { 'date-parts': [[2024, 9, 17]], 'date-time': '2024-09-17T17:58:18Z', 'timestamp': 1726595898000}, 'score': 1, 'resource': { 'primary': { 'URL': 'https://diabetesjournals.org/care/article/doi/10.2337/DCa24-0032/157171/Prevalent-Metformin-Use-in-Adults-With-Diabetes'}}, 'subtitle': [], 'short-title': [], 'issued': {'date-parts': [[2024, 9, 17]]}, 'references-count': 0, 'URL': 'http://dx.doi.org/10.2337/DCa24-0032', 'relation': {}, 'ISSN': ['0149-5992', '1935-5548'], 'subject': [], 'published': {'date-parts': [[2024, 9, 17]]}}
Loading..
Please send us corrections, updates, or comments. c19early involves the extraction of 100,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit